期刊文献+

对急性冠脉综合征患者MMP-2水平的研究 被引量:1

Study for MMP-2 level in patients with acute coronary syndrome
下载PDF
导出
摘要 目的:探讨血清基质金属蛋白酶(MMP-2)在急性冠脉综合征(ACS)发病中的作用及其与冠心病病变程度的关系。方法:选择100例冠心病患者,其中稳定型心绞痛(SAP)患者50例(SAP组)和ACS患者50例(ACS组),另选20例健康体检者作为健康对照组。检测各组患者的血脂,血清高敏C反应蛋白(hsCRP)、心肌肌钙蛋白I(eTnI),MMP-2水平,并进行比较分析。结果:(1)与健康对照组比较,ACS组和SAP组甘油三酯水平显著升高,高密度脂蛋白水平显著降低;cTnI[(0.011±0.024)μg/L、(O.019±0.026)μg/L比(1.113±4.220)μg/L]水平显著升高,且ACS组cTnI水平显著高于SAP组(P〈0.05~〈0.01);(2)与健康对照组和SAP组比较,ACS组hsCRP[(0.59±0.32)pg/ml、(1.40±1.90)pg/ml比(4.79±4.31)pg/ml]水平、MMP-2[(0.30±0.14)pg/L比(0.38±0.78)μg/L比(0.58±0.54)μg/L]水平显著升高(P均〈0.01);(3)Pearson线性相关分析显示,各组血清MMP-2与血清hsCRP具有明显正相关(r=0.374,P〈0.01)。结论:MMP-2水平升高可能与急性冠脉综合征的发病有关,MMP-2水平检测对急性冠脉综合征的早期诊断和治疗具有一定的应用价值。 Objective.. To explore role of serum matrix metalloproteinase - 2 (MMP - 2) in onset of acute coronary syndrome (ACS) and its relationship with diseased degree of coronary heart disease (CHD). Methods: A total of 100 CHD patients were selected, including 50 cases with stable angina pectoris (SAP, SAP group) and 50 ACS patients (ACS group). Another 20 healthy subjects were enrolled as healthy control group. Levels of blood lipids, serum high sensitive C reactive protein (hsCRP), cardiac troponin I (cTnI) and MMP- 2 were measured, compared and analyzed in all groups. Results: (1) Compared with healthy control group, there was significant increase in triglyceride level, significant decrease in high density lipoprotein level; and significant increase in cTnI [ (0. 011 ± 0. 024) μg/L vs. (0. 019 ± 0. 026)μg/L vs. (1. 113 ± 4. 220) μg/L] in SAP group and ACS group, furthermore the cTnI level of ACS group was more than that of SAP group P〈0.05-〈0.01; (2) Compared with healthy control group and SAP group, the hsCRP [ (0.59 ± 0.32) pg/ml, (1.40 ± 1.90) pg/ml vs. (4.79 ± 4.31) pg/ml], MMP- 2 [ (0.30 ± 0.14) μg/L, (0.38 ± 0.78)μg/L vs. (0.58 ± 0.54) μg/L] level significantly increased (P〈0. 01 all) in ACS group; (3) Pearson rectilinear correlation analysis indicated that serum MMP-2 was positively correlated with serum hsCRP (r = 0. 374, P(0.01) in all groups. Conclusion.. Increased MMP- 2 level may be related with occurrence of acute coronary syndrome, and its detection possesses certain application value for early diagnosis and treatment of acute coronary syndrome.
出处 《心血管康复医学杂志》 CAS 2013年第6期546-549,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
基金 黑龙江省教育厅课题(12511307) 黑龙江省科技计划项目(GC12D305)
关键词 冠状动脉疾病 C反应蛋白质 明胶酶A Coronary artery disease C- reactive protein Gelationase A
  • 相关文献

参考文献13

  • 1朱国旺.我国启动急性冠脉综合征临床路径研究[J].中国医药报,2011,8(13):89-106. 被引量:2
  • 2Ross R. Atherosclerosis-an inflammatory disease [J]. N Engl JMed, 1999,340 (2): 115 - 126. 被引量:1
  • 3Falk E,Nakano M, Bentzon JF, et al. Update on acute coro-nary syndromes: the pathologists' view [J]. Eur Heart J,2013, 34 (10): 719-728. 被引量:1
  • 4Barbash GI, White HD, Modan M, et al. Acute myocardial in-farction in the young-the role of smoking. The Investigators ofthe International Tissue Plasminogen Activator/StreptokinaseMortality Trial [J]. Eur Heart J, 1995,16 (3) : 313 - 316. 被引量:1
  • 5Fournier JA, Sainchez A, Quero J. et al. Myocardial infarctionin men aged 40 years or less: a prospective clinical angiographicstudy [J]. Clin Cardiol,1996,19 (8): 631 - 636. 被引量:1
  • 6Calabro P,Willerson JT,Yeh ET. Inflammatory cytokines stim-ulated C-reactive protein production by human coronary arterysmooth muscle cells [J], Circulation, 2003, 108 (16) : 1930 -1932. 被引量:1
  • 7Sattar N,Gaw A, Scherbakova O, et al. Metabolic syndromewith and without C-reactive protein as a predictor of coronaryheart disease and diabetes in the West of Scotland Coronary Pre-vention Study [J], Circulation, 2003,108 (4) : 414 - 419. 被引量:1
  • 8王曼,李建伟,卓鹏展.高敏C反应蛋白与急性冠脉综合征的相关性[J].心血管康复医学杂志,2012,21(4):376-379. 被引量:10
  • 9刘春辉,贺兆发,乔峰.不稳定型心绞痛患者血清MMP-2的含量及其与抗脂质过氧化治疗的关系[J].心血管康复医学杂志,2011,20(1):41-44. 被引量:14
  • 10Pearson TA, Mensah GA, Alexander RW, et al. Markers ofinflammation and cardiovascular disease: application to clinicaland public health practice: A statement for healthcare profession-als from the Centers for Disease Control and Prevention and theAmerican Heart Association [J]. Circulation, 2003,107 (3):499-511. 被引量:1

二级参考文献26

  • 1左鲁宁,陶志刚.高敏C反应蛋白与冠心病相关性分析[J].实用医技杂志,2007,14(7):904-905. 被引量:2
  • 2张清华,田莉,蒋知新,陈东.基质金属蛋白酶-9和妊娠相关血浆蛋白酶A及hs-CRP与急性冠脉综合征的相关性[J].心血管康复医学杂志,2007,16(2):142-144. 被引量:5
  • 3Godis ZS, Muszynski M, Sukhova Gk, et al. Cytokine-stimalated human vascular smooth muscle cells synthesize a complement of enzymes required for extrecellular matrixdigestion[ J]. Circ kes, 1994,75:181. 被引量:1
  • 4UzuiH, Lee JD, Shimizu H, et al. The role of protein tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells[ J]. Atheroscleresis, 2000,149( 1 ) : 51. 被引量:1
  • 5Newby AC zahsman AB. Molecular mechanisms in intimal hyperplasia [J]. J pathol,2000,190(3) :300. 被引量:1
  • 6Moreno PR, F alk E, palacios IF. Mucrophage infiltration in acute coronary syndromes[ J]. Circulation, 1994,90: 775. 被引量:1
  • 7Hisashi K,Hisao O,Hida,et al.Peripheral blood levels of matrix metallo proteinase-9 and-2 are elevated in patients with acute coronary syndromes[J].J Am Coll Cardiol,1998,32(2):368-372. 被引量:1
  • 8Ikeka U,Shimada K.Pleiotropic effects of satatins on the vascular tissue[J].Curr Drug Targets-Cardiovasc Haematol Dis,2001,1:51-58. 被引量:1
  • 9Libby P. Molecular bases of the acute coronary syndromes [J] Circulation, 1995, 91 (1): 2844-2250. 被引量:1
  • 10Danesh J, Wheeler JG, Hirschield GM, et al. Creactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J]. N Engl J Med, 2004, 350 (14): 1387-1397. 被引量:1

共引文献26

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部